Introduction
Mucus protects the various mucosal surfaces of the body and represents a major hindrance for particulate drug delivery to the underlying mucosal epithelium [1] [2] [3] . The mucus hydrogel forms a steric barrier and promotes clearance of pathogens, e.g. viruses, trapped within the mucus network network [2, 4, 5] . Similarly drug carriers that are incapable of diffusing fast enough through the mucus are held within the adhesive network and degraded prior to their delivery to the target absorptive epithelial membrane site [1] [2] [3] [4] . Permeating the mucus barrier is a major requirement for successful drug targeting to mucosal tissues. Several strategies to overcome the mucus barrier were recently summarized by Dünnhaupt [6] . Nano particulate systems, bearing enzymatically active compounds or systems possessing a 'slippery surface', as well as 'zeta-potential changing systems' are described in literature [7] [8] [9] [10] . Among various approaches, SEDDS emerged to have beneficial features to overcome the mucosal barrier. As shown by Friedl et al. [11] , the composition of SEDDS has great impact on their mucus permeating properties. SEDDS consist of an oily phase, containing oil(s), a surfactant(s) and co-surfactant that emulsifies spontaneously upon mixing in an aqueous environment [12, 13] .
The resulting droplets are typically in the nanometer scale (< 100 nm) favorable for the diffusion through mucus as the mucus is reported to express 50% of its pores below a size of 200 nm [14, 15] . As the dynamic properties of mucus remain a considerable challenge for drug targeting, novel mucus permeating systems are needed.
The aim of the study was the development of a novel mucus permeating system based around thiolated SEDDS. The strategy was to equip a nano-emulsion with thiol-moieties that are likely to interact with mucus, leading to a destruction of disulfide bonds of mucus network. This could be realized by the design of a series of novel thiolated emulsifiers based on modified fatty acid derivatives, which structure identification was assessed via NMR. Ease of incorporation of the novel highly lipophilic thiol-conjugates into SEDDS led to stable 4 thiolated oil-in-water nano-emulsions which were spontaneously formed upon dilution in aqueous environment, namely thiolated SEDDS.
The novel thiolated SEDDS were evaluated for their cytotoxicity and their muco-interactive features. Mucus permeating capacity of the novel designed thiolated SEDDS was evaluated using common in vitro models based on multiple particle tracking and on rotating silicone tubes. Mucolytic activity of the novel thiolated conjugates was studied using in vitro rheological measurements. In addition, computational predictions of the partition coefficient of the novel thiolated conjugates were provided.
Materials and Methods

Materials
Dodecylamine was purchased from Merck Millipore, Austria. Iminothiolane hydrochloride and SATA ((2,5-dioxopyrrolidin-1-yl) 2-acetylsulfanylacetate) were purchased from Santa Cruz, Biotechnology Heidelberg, Germany. Cremophor EL was purchased from BASF, Germany. Captex 355 and Capmul MCM were obtained from Abitec Corporation, United
States. Propylene glycole was obtained from Gatt-Koller, Absam Austria.
Fluoresceindiacetate (FDA) and N-acetylcysteine (NAC) and DTT (dithiothreitol) were purchased from Sigma-Aldrich, Austria. MEM (minimal essential medium) with and without phenol red was purchased from Sigma-Aldrich, Austria. Lumogen ® dye was bought from Kremer, Germany. All other chemicals were of analytical grade and from commercial sources. Silicone tubes were obtained from Lactan, Austria.
Methods
Synthesis of thiolated conjugates
Synthesis of TBA-D In a round bottom flask 1.816 mmol dodecylamine (1 eqv), 1.816 mmol iminothiolane hydrochloride (1 eqv) and 1.998 mmol triethylamine (1.1eqv) were dissolved in a mixture of 10 ml acetonitrile and 4 ml methanol. The solution was stirred at room temperature for approximately 4 h and the solvent was removed under reduced pressure. The crude product was purified via chromatography over silica as stationary phase and diethyl ether 100% as mobile phase to yield the product as a colorless liquid (yield = 55±5%) ( Figure 1A ). Finally the product was stored under inert gas at -20 °C until further use.
Synthesis of TGA-O
In the first reaction step, 2 mmol octylamine (1 eqv), 2 mmol SATA (1 eqv) and 0.2 mmol triethylamine (0.1 eqv) were dissolved in 10 ml acetonitrile in a round bottom flask. The 6 solution was stirred at room temperature and monitored with thin layer chromatography. After 2.5 h, the solvent was removed under reduced pressure. The crude product was purified via chromatography over silica as stationary phase using a mixture of petroleum ether and ethyl acetate (7:3) as mobile phase to yield the protected thioester (product A) as a white solid ( Figure 1B ). In the second step the thioester was hydrolysed by suspending TGA-octylaminethioester, hydroxylamine hydrochloride, EDTA (2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetic acid) and sodium hydrogen carbonate in a mixture of water and methanol (1:1). The pH was adjusted to pH 7 and the suspension was stirred at room temperature under thin layer chromatographic monitoring. After approximately 3 h, when the reaction had reached completion the product was extracted with dichloromethane. The organic phases were combined and dried with anhydrous sodium sulfate and the solvent was removed under reduced pressure. The product was purified via chromatography over silica as stationary phase using a mixture of dichloromethane and ethyl acetate (6:4) as mobile phase to yield the TGA-O as a colorless liquid (yield = 70±6%). Finally the product was stored under inert gas at -20°C until further use.
Identification of thiolated compounds: NMR analysis
The thiol conjugates were analyzed by 1 
SEDDS characterisation
The stability of SEDDS was confirmed via a centrifugation test of 12,100 g for 20 min using minispin centrifuge, Eppendorf, Germany. In addition, the particle size was monitored prior to experiment via an extended shelf-life study up to 12h using bis-ris buffer pH 6.0, 0.1M in a 1:100 dilution. To estimate stability of SEDDs in cell culture medium, preliminary tests were performed exemplarily for SEDDS A using white MEM as dispersing agent.
Size, zeta potential and polydispersity index of SEDDS formulations were determined by photon correlation spectroscopy using Nicomp PSS 380 DLS/ZLS, Particle Sizing Systems, Inc. Port Richey, Florida with a laser wavelength of 650 nm and an E-fields strength of 5 V/cm. The experiment was performed at room temperature.
Cell viability assay-resazurin assay
The potential cytotoxic effect of the thiolated SEDDS was evaluated using the resazurin assay on a human colon carcinoma cell line monolayer according to a protocol previously reported by our research group [17] . Caco-2 cells were cultured over a period of 14 days in 24-well plates. After seeding the cells (d=25 x 10 3 cells/well) they were fed with 500 µl of minimal essential medium (MEM) supplemented with 20% fetal bovine serum (FBS) at 37 °C in 5% 
In vitro mucus permeation studies
Mucus refinement
Freshly isolated pig intestinal ileum (5 m length from proximal region) was obtained from a local abattoir and kept in ice-cold oxygenated phosphate buffered saline (PBS) prior to sample processing. The ileum was processed into 25 cm lengths with each length then incised longitudinally. Food and other waste debris were gently rinsed away by ice-cold PBS. The mucus was then gently scraped from the intestinal surface with a spoon to avoid excessive shedding of intestinal epithelial tissue. Mucus was divided into aliquots (0.5 g) and kept at -20 °C prior to experimentation [19] .
In vitro permeation study-multiple particle tracking (MPT) in mucus
The effect of thiolated compounds on droplets permeation within mucus was studied using MPT technique according to a protocol reported previously [15] . Therefore, the formulations were labelled with the fluorescent dye Lumogen ®. Diffusion of SEDDS droplets through intestinal mucus was assessed by MPT [20] a technique that can track particle displacement with a tracking resolution (σ) to within 5 nm [21] . In this study the 'tracking resolution' (σ) was experimentally determined for each SEDD particle type. Specifically, σ was measured by gluing (cyanoacrylate-based glue) the particles to a glass bottom imaging dish followed by drying and setting of the glue matrix and video microscopy capture ( throughout it is entire 30-frame trajectory. The MSD was determined as follows [23] :
In any single experiment an MSD was calculated for at least 120 individual droplets with the experiment replicated a further two times, i.e. 360 droplets studied in total. For each droplets species under study an "ensemble mean square displacement" (defined by ‹MSD›) was determined for each of the three replicate studies.
The effective diffusion coefficient (‹Deff›) for a particular droplets species was then calculated by:
where 4 is a constant relating to a 2-dimensional mode of video capture and ∆t is the selected time interval.
Proportion of diffusive droplets: Measuring droplet diffusion across various time intervals
allows description of the proportion of droplets that are diffusive through the mucus matrix [22] . Equation 3 was used to determine a diffusivity factor (DF) which expresses the effective diffusion coefficient for each individual droplet (Deff) across the time intervals (∆t) of 1 s and
where the individual droplet Deff = MSD/(4 * ∆t). Droplets with a DF value of 0.9 and greater were defined as diffusive. The proportion of diffusive droplets within a given droplets type was then calculated and expressed as % Diffusive droplets. Droplet diffusion in water: The droplets' diffusion coefficient (D°) in water was calculated by the Stokes-Einstein equation at 37 C° [24] :
Heterogeneity in droplet diffusion
where κ is Boltzmann constant, T is absolute temperature, η is water viscosity, r is radius of the droplet. The diffusion of all droplets was also expressed as the parameter, % ratio [Deff] /
[D°].
In vitro mucus diffusion study-rotating tube method
The permeation study was performed according to a protocol previously reported by our research group [25] . In brief, silicon tubes (Ø=3 mm) were filled with a volume of 200 µl of mucus and closed at one end, then 50 µl of formulation was applied to the open end of the tube and then closed using silicone plug. Formulation was labeled with 0.3% fluoresceine diacetate and diluted in a 1:100 dilution of bis-tris-buffer (0.1M) pH 6. The tubes were placed in an incubator with a rotating device at gentle rotation for a time period of 4 hours at 37 °C.
Then the samples were frozen at -80°C for at least 1 hour. Then the tubes were cut-starting from the point where the mucus was added-into 10 slices of 2 mm each, and to each slice of mucus containing sample 300 µl of 5 M sodium hydroxide solution were added. In order to activate the fluorescent dye, the slices were incubated for 6 hours and fluorescence was measured at a wavelength of λ exc = 480 nm and λ em = 520 nm with a microplate reader (Tecan; Grödig; Salzburg, Austria). The amount of fluorescein diacetate in each slice was quantified using a standard calibration curve. Samples containing only mucus were additionally analysed-serving as blank. The experiment was performed in quintuplicate.
In vitro study of mucolytic activity
Mucolytic activity was assessed according to a technique previously reported by our research group using a plate-plate combination rheometer (Haake Mars Rheometer, 379-0200, Thermo
Electron GmBH, Karlsruhe, Germany; Rotor: PP35, D=35 mm) [26] . After determining the linear viscoelastic region of the gels using the oscillating modulus, the shear stress rate was set to a range of 0.1-2 Pa, with a frequency of 1 Hz at a temperature of 37±1°C and the gap between two plates was chosen about 0.5 mm. The rheological study was performed with the pure thiol-conjugates TBA-dodecylamine and TGA-octylamine using DTT as positive
control. An ethanolic solution of 30 µmol, in reference to the thiol groups of each respective conjugate, was dissolved in 100µl of EtOH and mixed with mucus in a ratio of 1:10 (V/m).
Mucus, diluted with the same amount of EtOH and treated the same way as the samples served as 100 % control for each respective time point. Samples were stored air tight at 37±1°C until rheological analysis was performed. Each measurement was done in quintuplicate.
Statistical data analysis
Statistical data analysis was performed using the student t-test with p < 0.05 as the minimal level of significance. The results are expressed as the means of at least 3 experiments ± SD." ppm. In both spectra it is possible to see the proton connected to the nitrogen at 6.19 ppm and 6.69 ppm.
The structure of the products was confirmed by NMR spectroscopy (see Appendix A-E). 
TBA-D 1 H-NMR
Preparation, stability and characterization of SEDDS
After 20 min at 12,100 g no visible phase separation could be detected. In addition, the extended shelf-life study as shown in Figure 3 demonstrated, that the size of the droplets remains stable over 12 h. The polydispersity index and the zeta potential showed no significant change in respect to time point zero. In addition, preliminary tests which were performed exemplarily for SEDDS A using white MEM as dispersing agent ensure particle size of approximately 38.2 nm. As shown in Figure 3 , droplet size measurements showed a diameter ranging from 36.91 nm to 53.39 nm which is smaller than the mucus average pore size, being reported to range from 20-200 nm [22, 27, 28] . The incorporation of the thiolated compounds led to no change in size. In addition, the influence on the surface charge is quite limited as the surface charge of the measured formulations was between -0.8 ± 0.9 mV and -7.1 ± 0.2 mV (see Table 1 ). Cytotoxicity studies on CaCo-2 cell monolayer proved cell viability of the SEDDS formulations of at least 90 % over a time period of 6 hours, indicated by reduction of resazurin to fluorescent resorufin by viable cells (Figure 2) [18].
3.3. In vitro permeation studies 3.3.
Multiple particle tracking (MPT) in mucus
Incorporation of the thiolated compounds led to an increase in ‹Deff›, which is most pronounced for the formulation termed SEDDS A, with a 66-fold increase (Table 1) in ‹Deff›, compared to the non-thiolated SEDDS C. Plotting the ‹Deff› versus droplet size ( Figure 3) indicates that droplet per se is not the primary determinant of this improved ‹Deff› and that steric obstruction is unlikely to be influential in the diffusion of any of the SEDDS formulations. The SEDDS droplets's sizes were smaller than the average mucus pore size, which is reported to be in the range of 20-200nm [22, 27, 28] . The porcine mucus, commonly used in in-vitro models, was harvested in a way to collect the loose and the adherent mucus layers. According to Abdulkarim et al., this technique leads to a median pore size of within the mucus mesh of ca. 200 nm with greater than 90% of the pores larger than 100 nm [15] .
Additionally, electric or ionic interactions seem to have little to no significant influence on the ‹Deff›. All SEDDS, even the SEDDS C as negative control, which was not containing any thiol-compound, showed motility in the mucus. This might be explained by the fact that a neutral or slightly negative surface charge is favorable for particles to pass through the mucin fiber network [22, 27, 29, 30] . Although the work of Allen et al. [29] refers to gastric and not intestinal mucus, the results are in agreement with the literature [29] . The formulations, used within this study fulfill this fundamental requirement as no hindrance due to ionic interaction, for example, with negatively charged mucoglycoproteins can be detected. Some viruses are reported to be highly efficient mucus permeating, an essential feature for their highly infective potential [31] . The ‹Deff› obtained for thiolated SEDDS A in this study is superior to the diffusion data (assessed using the same model system) obtained for capsid adenoviruses (146 nm diameter) by some 20-fold [15] .
The ratio of ‹Deff› to D° provides a measure of the efficiency of the diffusion of the droplets through mucus after the size of the droplet is account for. The ratio normalizes for the Table 1 , and show consistency with the overall population ‹Deff› data. Specifically, the SEDDS A formulation showed a considerably greater DF than any of the other droplet formulations with 59% of the SEDDS A droplets defined as diffusive compared to only 16% for the control SEDDS C formulation. The DF data obtained for all thiolated SEDDs in this study exceeded the DF data (assessed using the same model system) previously reported for capsid adenoviruses (19%) and by PEGylated particles (32%) [15] .
Further analysis of the heterogeneity in diffusion within each of the SEDD formulations was undertaken whereby the Deff for each individual droplet within a formulation was determined and the resulting Deff measurements ranked into percentiles ( Figure 5) . A more detailed analysis of the heterogeneity in the movement of individual droplets through mucus can provide insight into how different droplet subpopulations within a given formulation type may exploit divergent permeation pathways [15] . Of the thiolated SEDDS, formulation A was the more homogenous in terms of droplet diffusion with an approximate 20-fold difference between 90 th percentile (i.e. the Deff value below which 90 % of the Deff observations may be found) and 10 th percentile (i.e. the Deff value below which 10 % of the Deff observations may be found); the SEDDS B and SEDDS NAC formulations showed approximately 60 and 100-fold differences. The non-thiolated formulation, SEDDS C, show a much higher degree of heterogeneity (x1000-fold different) with only 60% of the particles showing negligible to no movement in the mucus. Even the fastest sub-populations of droplets for SEDDS C were below the median rates seen for SEDDS A.
In vitro mucus diffusion study-rotating tube method
The second evaluation of mucus-droplet interaction was done with a static in-vitro model.
Therefore, diffusion of SEDDS was assessed using a setup of rotating silicone tubes filled with mucus and using FDA as model drug. The study supported aforementioned data with significant advanced permeation of SEDDS A in respect to control SEDDS C omitting any thiol-conjugate (p < 0.05) ( Figure 6 ). The diffusion profile reported, follows a first order kinetics, and the SEDDS containing TBA-D show a significant increased concentration of FDA in comparison to SEDDS C within the first three slices. The negative control, being
represented by SEDDS C did not show any significant permeation of droplets than in slice 3.
The silicone tube test results were conclusive to the data obtained from MPT technique, although different fluorescent dyes were used and different experimental set-up were performed.
In vitro study of mucolytic activity
As demonstrated in two independent studies, the novel SEDDS showed mucus diffusive capacity. The thiolated ingredients, being the single difference between the different formulations were thus characterized for their muco-interactiv properties, which was assessed rheologically by monitoring the decrease in dynamic viscosity of small intestinal porcine mucus. All tested compounds showed a decrease in dynamic viscosity of mucus over a time period of one hour, leading to decrease in dynamic viscosity of up to 73.4 ± 6.6 % in respect to the negative control, which consisted of mucus and the solubilizing agent EtOH in an equal amount as in the samples (Figure 7) . DTT was used in equimolar amount in respect to the free thiol groups of the molecule. Reports about a more pronounced potency of DTT to reduce viscosity of mucus in comparison to NAC led to the choice of DTT as most suitable control [32] . Mucolytic agents expressing a free thiol moiety such as NAC as leading structure are reported to reduce the cross-linking of mucin-fibres by cleaving disulphide bonds and thus reduce the bulk mucus viscosity [16] . The data obtained show a decrease in viscosity for all three molecules, TBA-D, TGA-O and NAC and show structural similarity to NAC by expressing a free thiol group. The mucolytic activity of the novel synthesized excipient is probably based on a disulphide exchange reaction between the thiol-conjugates and the cysteine thiol group in the mucin fibres [5, 33, 34] . Consequently, the authors assume that the enhancement of droplets diffusion through the mucus is favored due to the incorporated thiolconjugates.
Computational calculations of the partition coefficients of all used thiolated molecules were calculated by chemsketch [35] ( Table 2) . The authors assume, that the high partition coefficient of the thiol-conjugates TBA-dodecylamine and TGA-octylamine leads to a stable incorporation of the thiol-conjugates in the SEDDS while the more hydrophilic controls are leaking more quickly giving evidence of a less pronounced and less long lasting effect. The SEDDS droplets, exhibiting a highly lipophilic core, shelter the novel thiol-conjugates, leading to a sustained release due to a leakage of the compounds into the aqueous environment. This continuous and sustained release leads to facilitated mucus permeation, presumable due to a destruction of the mucin network. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript. 
